A Dual Altered Peptide Ligand Inhibits Myasthenia Gravis Associated Responses by Inducing Phosphorylated Extracellular-regulated Kinase 1,2 that Upregulates CD4+CD25+Foxp3+Cells-Reference-Cited by-同舟云学术

A Dual Altered Peptide Ligand Inhibits Myasthenia Gravis Associated Responses by Inducing Phosphorylated Extracellular-regulated Kinase 1,2 that Upregulates CD4+CD25+Foxp3+Cells

Published:2007-06 Issue:6 Volume:65 Page:567-576
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:Scand J Immunol

Author:

Ben-David H.,Venkata Aruna B.,Sela M.,Mozes E.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2007.01940.x/fullpdf

Reference35 articles.

1. Myasthenia Gravis

2. Myasthenia Gravis

3. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.

4. A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis;Journal of Neuroimmunology;2017-06

2. Taming the TCR: Antigen-Specific Immunotherapeutic Agents for Autoimmune Diseases;International Reviews of Immunology;2015-05-13

3. Autoimmunity: limited progress for the patient, despite decades of research;Scandinavian Journal of Immunology;2009-11

4. Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases;Immunotherapy;2009-05

5. Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in Psoriasis vulgaris;Journal of Dermatological Science;2008-09